• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自囊性纤维化注册机构的国际文献综述:1. 囊性纤维化的死亡率和生存研究。

An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis.

作者信息

Buzzetti R, Salvatore D, Baldo E, Forneris M P, Lucidi V, Manunza D, Marinelli I, Messore B, Neri A S, Raia V, Furnari M L, Mastella G

机构信息

Italian Cystic Fibrosis Research Foundation, Verona, Italy.

出版信息

J Cyst Fibros. 2009 Jul;8(4):229-37. doi: 10.1016/j.jcf.2009.04.001. Epub 2009 May 6.

DOI:10.1016/j.jcf.2009.04.001
PMID:19419909
Abstract

Patient registries are organized systems of data collection for scientific, clinical or health strategy purposes. Aims of our review were to document scientific literature based on data and information from cystic fibrosis (CF) registries; to understand which clinical problems have been addressed and for which of these the studies concerned have correctly answered the questions raised (i.e. a methodological critique) and to identify clinical issues in need of further investigation. The review included primary studies starting from a formally constituted CF registry of at least national level, using data from the registry to evaluate research hypotheses. This article is an overview of the research undertaken, focusing in detail on the issues of mortality and survival. The studies considered here focused mainly or secondarily on survival in CF, the aim being to ascertain an improving trend, identify any prognostic factors and, in some cases, attempt to provide a predictive model of survival.

摘要

患者登记系统是为科学、临床或健康战略目的而组织的数据收集系统。我们本次综述的目的是基于囊性纤维化(CF)登记处的数据和信息记录科学文献;了解哪些临床问题已得到解决,以及相关研究对所提出的问题给出了正确答案的情况(即方法学批判),并确定需要进一步研究的临床问题。该综述纳入了至少从国家级正式建立的CF登记处开展的初步研究,利用登记处的数据来评估研究假设。本文是对所开展研究的概述,详细聚焦于死亡率和生存率问题。这里所考虑的研究主要或次要关注CF患者的生存情况,目的是确定改善趋势、识别任何预后因素,并且在某些情况下尝试提供生存预测模型。

相似文献

1
An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis.来自囊性纤维化注册机构的国际文献综述:1. 囊性纤维化的死亡率和生存研究。
J Cyst Fibros. 2009 Jul;8(4):229-37. doi: 10.1016/j.jcf.2009.04.001. Epub 2009 May 6.
2
An overview of international literature from cystic fibrosis registries. Part 3. Disease incidence, genotype/phenotype correlation, microbiology, pregnancy, clinical complications, lung transplantation, and miscellanea.囊性纤维化登记处国际文献概述。第 3 部分。发病情况、基因型/表型相关性、微生物学、妊娠、临床并发症、肺移植和杂项。
J Cyst Fibros. 2011 Mar;10(2):71-85. doi: 10.1016/j.jcf.2010.12.005. Epub 2011 Jan 22.
3
Stature as a prognostic factor in cystic fibrosis survival.身高作为囊性纤维化患者生存的一个预后因素。
J Am Diet Assoc. 2001 Apr;101(4):438-42. doi: 10.1016/S0002-8223(01)00113-4.
4
Using disease registries for pharmacoepidemiological research: a case study of data from a cystic fibrosis registry.利用疾病登记系统进行药物流行病学研究:以囊性纤维化登记系统的数据为例
Pharmacoepidemiol Drug Saf. 2003 Sep;12(6):467-73. doi: 10.1002/pds.804.
5
An overview of international literature from cystic fibrosis registries 2. Neonatal screening and nutrition/growth.囊性纤维化注册研究的国际文献概述 2. 新生儿筛查和营养/生长。
J Cyst Fibros. 2010 Mar;9(2):75-83. doi: 10.1016/j.jcf.2009.11.002. Epub 2009 Dec 2.
6
An overview of international literature from cystic fibrosis registries. Part 4: update 2011.国际囊性纤维化登记处文献概述。第 4 部分:2011 年更新。
J Cyst Fibros. 2012 Dec;11(6):480-93. doi: 10.1016/j.jcf.2012.07.005. Epub 2012 Aug 9.
7
Improved survival among young patients with cystic fibrosis.囊性纤维化年轻患者的生存率提高。
J Pediatr. 2003 Jun;142(6):631-6. doi: 10.1067/mpd.2003.197.
8
Cystic fibrosis mortality: registry data of cystic fibrosis.囊性纤维化死亡率:囊性纤维化登记数据
J Insur Med. 1997;29(4):233-9.
9
Cystic fibrosis mortality trends in France.法国囊性纤维化的死亡率趋势
J Cyst Fibros. 2007 May;6(3):179-86. doi: 10.1016/j.jcf.2006.07.001. Epub 2006 Aug 17.
10
A specific database for providing local and national level of integration of clinical data in cystic fibrosis.一个用于提供囊性纤维化临床数据在地方和国家层面整合情况的特定数据库。
J Cyst Fibros. 2007 May;6(3):187-93. doi: 10.1016/j.jcf.2006.07.002. Epub 2006 Oct 5.

引用本文的文献

1
Cardiopulmonary Exercise Testing Provides Prognostic Information in Advanced Cystic Fibrosis Lung Disease.心肺运动试验在晚期囊性纤维化肺病中提供预后信息。
Ann Am Thorac Soc. 2024 Mar;21(3):411-420. doi: 10.1513/AnnalsATS.202304-317OC.
2
Bacterial Surface Detachment during Nebulization with Contaminated Reusable Home Nebulizers.雾化污染的可重复使用家用雾化器时细菌表面脱落。
Microbiol Spectr. 2022 Feb 23;10(1):e0253521. doi: 10.1128/spectrum.02535-21. Epub 2022 Feb 2.
3
The clinical effects of combining postural exercises with chest physiotherapy in cystic fibrosis: A single-blind, randomized-controlled trial.
体位锻炼联合胸部物理治疗对囊性纤维化的临床效果:一项单盲随机对照试验
Turk J Phys Med Rehabil. 2021 Mar 4;67(1):91-98. doi: 10.5606/tftrd.2021.5214. eCollection 2021 Mar.
4
Timing of dornase alfa inhalation for cystic fibrosis.吸入用胰蛋白酶原治疗囊性纤维化的时机。
Cochrane Database Syst Rev. 2021 Mar 9;3(3):CD007923. doi: 10.1002/14651858.CD007923.pub6.
5
Explaining the Sex Effect on Survival in Cystic Fibrosis: a Joint Modeling Study of UK Registry Data.解释囊性纤维化生存中的性别效应:英国注册数据的联合建模研究。
Epidemiology. 2020 Nov;31(6):872-879. doi: 10.1097/EDE.0000000000001248.
6
Timing of hypertonic saline inhalation for cystic fibrosis.囊性纤维化患者吸入高渗盐水的时机
Cochrane Database Syst Rev. 2020 Feb 28;2(2):CD008816. doi: 10.1002/14651858.CD008816.pub4.
7
Results from an online survey of adults with cystic fibrosis: Accessing and using life expectancy information.一项针对成年囊性纤维化患者的在线调查结果:获取和使用预期寿命信息。
PLoS One. 2019 Apr 12;14(4):e0213639. doi: 10.1371/journal.pone.0213639. eCollection 2019.
8
Squaramide-based synthetic chloride transporters activate TFEB but block autophagic flux.基于 Squaramide 的合成氯离子转运体激活 TFEB,但阻断自噬通量。
Cell Death Dis. 2019 Mar 11;10(3):242. doi: 10.1038/s41419-019-1474-8.
9
Mortality Due to Cystic Fibrosis over a 36-Year Period in Spain: Time Trends and Geographic Variations.西班牙 36 年间囊性纤维化死亡率:时间趋势和地域差异。
Int J Environ Res Public Health. 2019 Jan 4;16(1):119. doi: 10.3390/ijerph16010119.
10
Timing of dornase alfa inhalation for cystic fibrosis.囊性纤维化患者吸入多黏菌素B雾化液的时机。
Cochrane Database Syst Rev. 2018 Nov 12;11(11):CD007923. doi: 10.1002/14651858.CD007923.pub5.